Literature DB >> 33812668

Morbidity and mortality after anaesthesia in early life: results of the European prospective multicentre observational study, neonate and children audit of anaesthesia practice in Europe (NECTARINE).

Nicola Disma1, Francis Veyckemans2, Katalin Virag3, Tom G Hansen4, Karin Becke5, Pierre Harlet6, Laszlo Vutskits7, Suellen M Walker8, Jurgen C de Graaff9, Marzena Zielinska10, Dusica Simic11, Thomas Engelhardt12, Walid Habre7.   

Abstract

BACKGROUND: Neonates and infants requiring anaesthesia are at risk of physiological instability and complications, but triggers for peri-anaesthetic interventions and associations with subsequent outcome are unknown.
METHODS: This prospective, observational study recruited patients up to 60 weeks' postmenstrual age undergoing anaesthesia for surgical or diagnostic procedures from 165 centres in 31 European countries between March 2016 and January 2017. The primary aim was to identify thresholds of pre-determined physiological variables that triggered a medical intervention. The secondary aims were to evaluate morbidities, mortality at 30 and 90 days, or both, and associations with critical events.
RESULTS: Infants (n=5609) born at mean (standard deviation [sd]) 36.2 (4.4) weeks postmenstrual age (35.7% preterm) underwent 6542 procedures within 63 (48) days of birth. Critical event(s) requiring intervention occurred in 35.2% of cases, mainly hypotension (>30% decrease in blood pressure) or reduced oxygenation (SpO2 <85%). Postmenstrual age influenced the incidence and thresholds for intervention. Risk of critical events was increased by prior neonatal medical conditions, congenital anomalies, or both (relative risk [RR]=1.16; 95% confidence interval [CI], 1.04-1.28) and in those requiring preoperative intensive support (RR=1.27; 95% CI, 1.15-1.41). Additional complications occurred in 16.3% of patients by 30 days, and overall 90-day mortality was 3.2% (95% CI, 2.7-3.7%). Co-occurrence of intraoperative hypotension, hypoxaemia, and anaemia was associated with increased risk of morbidity (RR=3.56; 95% CI, 1.64-7.71) and mortality (RR=19.80; 95% CI, 5.87-66.7).
CONCLUSIONS: Variability in physiological thresholds that triggered an intervention, and the impact of poor tissue oxygenation on patient's outcome, highlight the need for more standardised perioperative management guidelines for neonates and infants. CLINICAL TRIAL REGISTRATION: NCT02350348.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  critical events; neonates; outcome; patient safety; quality

Mesh:

Substances:

Year:  2021        PMID: 33812668     DOI: 10.1016/j.bja.2021.02.016

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

Review 1.  [Quality and safe anesthesia for all children : That is their right!]

Authors:  Markus Weiss; Andreas Machotta
Journal:  Anaesthesist       Date:  2022-03-28       Impact factor: 1.041

2.  Dose-Related Analysis in Percutaneous Central Venous Catheters Insertion: Experience of a Pediatric Interventional Radiology Center.

Authors:  Gian Luigi Natali; Giulia Cassanelli; Claudia Polito; Vittorio Cannatà; Marco Martinelli; Massimo Rollo
Journal:  Children (Basel)       Date:  2022-05-06

3.  Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study.

Authors:  Alexander Fuchs; Nicola Disma; Katalin Virág; Francis Ulmer; Walid Habre; Jurgen C de Graaff; Thomas Riva
Journal:  Eur J Anaesthesiol       Date:  2022-03-01       Impact factor: 4.330

4.  Perioperative critical events and morbidity associated with anesthesia in early life: Subgroup analysis of United Kingdom participation in the NEonate and Children audiT of Anaesthesia pRactice IN Europe (NECTARINE) prospective multicenter observational study.

Authors:  Suellen M Walker; Thomas Engelhardt; Nargis Ahmad; Nadine Dobby
Journal:  Paediatr Anaesth       Date:  2022-05-01       Impact factor: 2.129

Review 5.  Developmental mechanisms of CPSP: Clinical observations and translational laboratory evaluations.

Authors:  Suellen M Walker
Journal:  Can J Pain       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.